Furthermore, Kaplan–Meier survival analysis revealed that patients of lung cancer with lower expression of Sp1 and higher expression of PDSS2 exhibited the best disease-free survival, rather than higher expression of Sp1 and lower expression of PDSS2 (Figure 7b). This evidence concerns the gene SP1 and lung carcinoma.